Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports Program. | CzeekV インデックス

HOME
>
論文・技術情報
>
Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports Program.

Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports Program.

アブストラクト
ジャーナル名	Journal of the American Academy of Dermatology
投稿日	2020/2/6
投稿者	Jimenez, Javier; Gwillim, Eran C; Kosche, Cory; Figueiredo, Anna; Rauck, Corrine; Rangel, Stephanie M; Choi, Jennifer; West, Dennis P; Nardone, Beatrice; Lacouture, Mario E
組織名	Department of Dermatology, Feinberg School of Medicine, Northwestern University,;Chicago, Illinois.;Chicago, Illinois. Electronic address: b-nardone@northwestern.edu.;Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer;Center, New York, New York.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/32014533/

タグ:

FAERS

お問合わせ

お問合わせ

検索

サイト内検索・論文検索

メルマガ登録

購読申し込み

Copyright© INTAGE Healthcare Inc. All Rights Reserved.